BUSINESS
Novartis to Acquire Myricx Bio for Up to $1.5 Billion
Novartis is buying UK biotech Myricx Bio for $1.1B upfront plus milestones, marking a major win for backer Sofinnova Partners.
EDITOR'S PICKS
Markets
View all 6 →Business
View all 6 →Personal Finance
View all 3 →
MOST READ
-
1
BUSINESS
Novartis to Acquire Myricx Bio for Up to $1.5 Billion
-
2
MARKETS
Crypto Clarity Inches Forward as Congress Heads on Break
-
3
PERSONAL FINANCE
Mortgage and Refinance Rates Jump Sharply This Week
-
4
MARKETS
Peter Brandt Eyes Gold Over Bitcoin in Portfolio Shift
-
5
MARKETS
Genesis Tables A$5.6B Binding Merger Bid for Vault Minerals